Our board of directors currently consists of 12 members. Aneel Bhusri serves as executive chair and Mark Hawkins is vice chair and lead independent director. Other board members include Tom Bogan; Liz Centoni; Lynne Doughtie; Carl M. Eschenbach (who is also our CEO); Wayne A.I. Frederick, M.D.; Mike McNamara; Rhonda Morris; Michael Speiser; George Still, Jr.; and Jerry Yang. Each of our directors, other than Aneel Bhusri and Carl Eschenbach, is "independent" as defined by the rules of the Nasdaq Global Select Market. We have a classified board of directors, with each class serving staggered three-year terms. In addition, we have established an Audit Committee, a Compensation Committee, a Nominating and Governance Committee, and an Investment Committee. Our board and committee structure, as well as biographies for each of our directors, are set forth below.